BEGIN:VCALENDAR
PRODID:-//AT Content Types//AT Event//EN
VERSION:2.0
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20120523T214919Z
CREATED:20080731T090651Z
UID:ATEvent-6816cd6dc58840eb2189f7de9cc688fb
LAST-MODIFIED:20080731T100758Z
SUMMARY:CHI’S TRANSLATIONAL CANCER MEDICINE
DTSTART:20090126T080000Z
DTEND:20090128T080000Z
DESCRIPTION:The increasing technological advances in biomarker and tar
 get discovery\, pre-clinical models\, personalized medicine\, and clin
 ical trial design have the potential to expedite the translation of ne
 w discoveries to clinical practice. Oncology is the area that has perh
 aps benefited the most from these new technologies. The Translational 
 Cancer Medicine meeting will identify the key opportunities to improve
  cancer diagnosis and treatment\, as well as provide case studies of s
 uccessful (and not so successful) drug development. The pre-conference
  workshop will provide a comprehensive survey of novel cancer biomarke
 rs. Translational Cancer Medicine is co-located with the Biomarker Ass
 ay Development meeting.
LOCATION:The Westin San Diego
CATEGORIES:Conference
CONTACT:CHI Representative\, 781 972 5400\, chi@healthtech.com
URL:http://www.healthtech.com/trm/overview.aspx?c=6593
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR